86 results
8-K
EX-4.3
BBLG
Bone Biologics Corp
6 Mar 24
Bone Biologics Announces Pricing of $2.0 Million Public Offering
4:20pm
with the investigation, preparation and prosecution of such action or proceeding.
f) Restrictions. The Holder acknowledges that the Warrant Shares acquired
8-K
EX-10.1
BBLG
Bone Biologics Corp
6 Mar 24
Bone Biologics Announces Pricing of $2.0 Million Public Offering
4:20pm
, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding, such as a deposition), whether commenced … ), there is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company, threatened against
8-K
EX-4.1
BBLG
Bone Biologics Corp
6 Mar 24
Bone Biologics Announces Pricing of $2.0 Million Public Offering
4:20pm
attorneys’ fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.
f
8-K
EX-4.2
BBLG
Bone Biologics Corp
6 Mar 24
Bone Biologics Announces Pricing of $2.0 Million Public Offering
4:20pm
for their reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action
S-3/A
EX-99.1
pax58ik49tv4s7xj25
17 Jan 24
Shelf registration (amended)
5:21pm
8-K
EX-10.1
wmcv6k
20 Nov 23
Bone Biologics Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
7:46am
8-K
EX-1.1
nv6miaa9iuww4
16 Jun 23
Bone Biologics Prices $5.0 Million Underwritten Public Offering
2:53pm